Teva Adds To Biosimilars Capabilities Through Partnership With Lonza

Even as big pharma continues to express interest in developing follow-on biologics, Teva has taken a step toward solidifying a leadership position in the space. The world's largest generic company announced a tie-up Jan. 20 with the privately held Swiss contract manufacturing group Lonza